Abatacept Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

COVID-19 VaccinE Response in Rheumatology Patients
Conditions:   Rheumatoid Arthritis;   Psoriatic Arthritis;   Spondylarthritis Interventions:   Drug: Upadacitinib;   Drug: Abatacept;   Drug: Secukinumab;   Drug: Tofacitinib;   Drug: TNF Inhibitor;   Drug: Canakinumab Injection Sponsors:   Jeffrey Curtis;   University of Alabama at Birmingham;   University of Nebraska;   University of Pennsylvania;   AbbVie;   Bristol-Myers Squibb;   Novartis;   Eli Lilly and Company;   Pfizer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 15, 2021 Category: Research Source Type: clinical trials